Merck Cash on Hand 2012-2026 | MRK

Merck cash on hand for the quarter ending March 31, 2026 was $18.214B, a 24.81% increase year-over-year.

  • Merck cash on hand for 2024 was $13.689B, a 92.99% increase from 2023.
  • Merck cash on hand for 2023 was $7.093B, a 46.23% decline from 2022.
  • Merck cash on hand for 2022 was $13.192B, a 62.94% increase from 2021.

Merck Cash on Hand 2012-2026 | MRK

  • Merck cash on hand for 2024 was $13.689B, a 92.99% increase from 2023.
  • Merck cash on hand for 2023 was $7.093B, a 46.23% decline from 2022.
  • Merck cash on hand for 2022 was $13.192B, a 62.94% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B